z-logo
open-access-imgOpen Access
Clinical importance of special aerosol formulation of tobramycin for treatment of chronic pulmonary disease in patients with cystic fibrosis
Author(s) -
Н И Капранов,
N. Kashirskaya,
А. М. Радионович,
Е. Л. Амелина,
Chuchalin Ag,
T. E. Gembitskaya,
A. G. Chermenskiy,
Alexander Orlov,
Guido Varoli,
P. Monici Preti
Publication year - 2008
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 6
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2008-0-3-20-26
Subject(s) - medicine , tobramycin , sputum , cystic fibrosis , placebo , adverse effect , sputum culture , gastroenterology , pseudomonas aeruginosa , surgery , pathology , tuberculosis , genetics , alternative medicine , bacteria , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here